Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Monnier

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancerT Le Chevalier, A Monnier, J Y Douillard, et al.
The FEBS Journal|November 20, 2023
The biophysical and compositional properties of human basement membranesMonica S Schoenenberger, Willi Halfter, Alexia Ferrand, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancerJ Bennouna, A Monnier, A Rivière, et al.
European Geriatric Medicine|May 11, 2022
Parkinson rehabilitation in nursing homes: a qualitative exploration of the experiences of patients and caregiversHester Fidder, Joannina J Jaski, Eskeline Elbertse, et al.
Chimia|March 1, 2019
Artificial Lysosomal Platform to Study Nanoparticle Long-term StabilityAna MilosevicAc, Joël Bourquin, David Burnand, et al.
British Journal of Cancer|May 29, 2003
Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancerA Lortholary, T Delozier, A Monnier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2005
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group resultsP Fumoleau, H Roché, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study GroupM Campone, H Roché, P Kerbrat, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 13, 2012
Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cellsM Doyard, N Fatih, A Monnier, et al.
Drugs|January 1, 1993
Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study GroupJ P Gérard, M Héry, D Gedouin, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancerT Le Chevalier, A Monnier, J Y Douillard, et al.
The FEBS Journal|November 20, 2023
The biophysical and compositional properties of human basement membranesMonica S Schoenenberger, Willi Halfter, Alexia Ferrand, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancerJ Bennouna, A Monnier, A Rivière, et al.
European Geriatric Medicine|May 11, 2022
Parkinson rehabilitation in nursing homes: a qualitative exploration of the experiences of patients and caregiversHester Fidder, Joannina J Jaski, Eskeline Elbertse, et al.
Chimia|March 1, 2019
Artificial Lysosomal Platform to Study Nanoparticle Long-term StabilityAna MilosevicAc, Joël Bourquin, David Burnand, et al.
British Journal of Cancer|May 29, 2003
Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancerA Lortholary, T Delozier, A Monnier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2005
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group resultsP Fumoleau, H Roché, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study GroupM Campone, H Roché, P Kerbrat, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 13, 2012
Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cellsM Doyard, N Fatih, A Monnier, et al.
Drugs|January 1, 1993
Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study GroupJ P Gérard, M Héry, D Gedouin, et al.
Pageof 16